Bloom Announces Early 2026 UK Launch, Expanding into Europe with New Garden Pharma as Exclusive Manufacturer
LONDON--(BUSINESS WIRE)--The Bloom Brand, a recognized U.S. leader in cannabis vape, is making its international debut in the United Kingdom through an exclusive partnership with New Garden Pharma, a leading European EU-GMP cannabis operator. Together, the two companies will launch Bloom's award-winning Classic and Live vape collections in the UK in Q1 2026.
Bloom Announces Early 2026 UK Launch, Expanding into Europe with New Garden Pharma as Exclusive Manufacturer.
Share
This marks Bloom's first international market expansion, as the company continues its global growth strategy with additional EU markets in development for 2026 and beyond. UK patients will gain access to Bloom's superior formulations and proprietary hardware systems.
For more than a decade, Bloom has built its reputation on delivering terpene-rich, flavor-forward strains paired with reliable technology. The brand has an established and leading presence across leading U.S. markets including California, Illinois, Florida, Michigan, Missouri, New Jersey, New Mexico, New York, and Virginia.
'Expanding into the UK is a pivotal step towards our mission to reshape the global cannabis experience,' said Ovidiu (David) Chiorpec, Director of Business Development at Bloom. 'We've spent over a decade building a brand that patients trust in the U.S., and we're excited to introduce the UK consumer to a new level of excellence and sophistication in the vape category.'
New Garden Pharma, medical subsidiary of New Garden Group, is a trusted name in European cannabis manufacturing who combines a unique supply chain model with a proven track record in regulatory compliance and market expansion. With established infrastructure across the continent, the company will lead Bloom's UK entry — ensuring a compliant, efficient, and scalable launch across all channels.
'We're excited to welcome Bloom to the UK market,' said Alexey Brylev, CEO of New Garden Group. 'As an established operator across European medical cannabis markets, we bring the EU-GMP manufacturing expertise, local insight, and regulatory know-how needed to help global brands thrive. This partnership reflects our broader mission: to deliver world-class products to European patients and to raise the bar for quality, safety, and innovation across the continent.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
European Banks Face Hit to Profits in S&P Trade War Stress Test
(Bloomberg) -- European banks would see their profits eroded if an escalation of trade tensions with the US leads to souring corporate loans, according to S&P Global Ratings. Bezos Wedding Draws Protests, Soul-Searching Over Tourism in Venice US State Budget Wounds Intensify From Trump, DOGE Policy Shifts Taxi Wars Put Johannesburg Commuters in Peril as Rail Flounders Credit Agricole and BPCE of France, Frankfurt-based Commerzbank, Dutch lender Rabobank and Denmark's DLR Kredit stand to be hit hardest, according to calculations by the credit ratings company. S&P said none of the 91 banks it examined were projected to face an annual loss in its stress test. The uncertainty over how the US will implement tariffs on trading partners has investors asking how big the hit will be for Europe. Yet the region's lenders, often seen as a proxy for the broader economy, face the latest shock with comparatively low levels of bad loans and profits that have been bolstered by higher interest rates. Bloomberg reported last month that a biennial regulatory stress test run by the European Central Bank and the European Banking Authority is on track to deliver a lesser hit to banks' capital ratios than the previous one. S&P's test included three hypothetical scenarios for how an escalation of trade tensions could play out. In the most severe, the median hit to banks' profit stood at 29%, the ratings company said in a report to be published on Tuesday. S&P said the five banks stood out because they had a combination of more exposure to sectors for which it applied higher loss rates, larger loan books compared to total assets, lower expected profitability and higher economic risk in the countries where they operate. 'We believe our stress test findings support our assessment that European banks have improved their resilience to credit risks substantially,' S&P analysts including Nicolas Charnay in Paris, wrote. 'They also underpin our expectation that upcoming regulatory stress tests conducted by authorities will likely reach similar conclusions.' The EBA and ECB are scheduled to publish results of their own examination at the beginning of August. Watchdogs draw on the results to determine how much capital banks should hold as a safety cushion, which in turn influences the amount of money they have available for investor payouts. Luxury Counterfeiters Keep Outsmarting the Makers of $10,000 Handbags Is Mark Cuban the Loudmouth Billionaire that Democrats Need for 2028? Ken Griffin on Trump, Harvard and Why Novice Investors Won't Beat the Pros Can 'MAMUWT' Be to Musk What 'TACO' Is to Trump? What Mike Tyson and the Bond Market Can Teach Trump on Debt ©2025 Bloomberg L.P. Sign in to access your portfolio
Bloomberg
30 minutes ago
- Bloomberg
NATO Cash Bonanza Risks Becoming Europe's Lost Chance for Growth
Europe's plans to unleash trillions of euros in new defense spending will be a huge missed opportunity unless the region can work out how to raise productivity in the process. Any economic benefits beyond bolstering its own military capacity are likely to be lost if countries don't change the way they invest in their armed forces, and develop and produce weapons. That's what calculations by Bloomberg Economics suggest, pointing to only a fleeting growth impact that peters out within three years.
San Francisco Chronicle
35 minutes ago
- San Francisco Chronicle
World shares rally after Trump announces what appears to be a shaky Israeli-Iran ceasefire
BANGKOK (AP) — Stocks rallied and oil prices fell on Tuesday after U.S. President Donald Trump announced what appears to be a shaky ceasefire in the Israel-Iran war. A tentative truce proposed by Trump remained uncertain after Israel said Iran had launched missiles into its airspace less than three hours after the ceasefire went into effect. It vowed to retaliate. Still, investors took heart after Trump said Israel and Iran had agreed to a 'complete and total ceasefire' soon after Iran launched limited missile attacks Monday on a U.S. military base in Qatar, retaliating for the American bombing of its nuclear sites over the weekend. The future for the S&P 500 gained 0.8% while that for the Dow Jones Industrial Average was up 0.6%. 'The Middle East may still be smoldering, but as far as markets are concerned, the fire alarm has been shut off,' Stephen Innes of SPI Asset Management said in a commentary. In early European trading, Germany's DAX leaped 1.8% to 23,679.64, while the CAC 40 in Paris added 1.2% to 7,631.07. Britain's FTSE 100 was up 0.4% at 8,789.91. In Asia, Tokyo's Nikkei 225 rose 1.1% to 38,790.56 and the Hang Seng in Hong Kong gained 2.1% to 24,177.07. The Shanghai Composite index climbed 1.2% to 3,420.57. In South Korea, the Kospi jumped 3% to 3,103.64, while Australia's S&P/ASX 200 gained 1% to 8,555.50. Taiwan's Taiex rose 2.1% and India's Sensex was up 0.6%. In Bangkok, the SET surged 2.5%. Oil prices fell further, after tumbling on Monday as fears subsided of an Iranian blockade of the Strait of Hormuz, a vital waterway for shipping crude. The price of oil initially jumped 6% after trading began Sunday night, a signal of rising worries as investors got their first chance to react to the U.S. bombings. But it quickly shed all those gains, with U.S. benchmark crude falling 7.2%. It dropped further early Tuesday, giving up 2.4% to $66.85 per barrel. It had briefly topped $78. Brent crude, the international standard, shed 2.4% early Tuesday to $68.83. U.S. stocks rallied on Monday despite the United States' bunker-busting entry into its war with Israel. The S&P 500 climbed 1% and the Dow industrials gained 0.9%. The Nasdaq composite index advanced 0.9%. Iran's retaliation for the U.S. attacks appeared not to target the flow of oil. The fear throughout the Israel-Iran war has been that it could squeeze supplies, pumping up prices for crude, gasoline and other products. Back in the U.S., Treasury yields eased after a top Federal Reserve official said she would support cutting rates at the Fed's next meeting, as long as 'inflation pressures remain contained.' The yield on the 10-year Treasury held steady at 4.33% from 4.38% late Friday. The two-year Treasury yield, which more closely tracks expectations for the Fed, dropped to 3.83% from 3.90%. The Federal Reserve has been hesitant to cut interest rates this year because it's waiting to see how much higher tariffs imposed by Trump will hurt the U.S. economy and raise inflation. Inflation has remained relatively tame recently, but higher oil and gasoline prices would push it higher. That could keep the Fed on hold because cuts to rates can fan inflation while they also give the economy a boost. On Wall Street, Elon Musk's Tesla was the single strongest force pushing the S&P 500 higher after jumping 8.2%. The electric-vehicle company began a test run on Sunday of a small squad of self-driving cabs in Austin, Texas. It's something that Musk has long been touting and integral to Tesla's stock price being as high as it is.
